ClinicalTrials.Veeva

Menu

Analysis the Positive Rate of Tumor Markers Among Physical Examination Population

P

Peking University

Status

Completed

Conditions

Tumor

Treatments

Other: no intervention

Study type

Observational

Funder types

Other

Identifiers

NCT05165147
IRB00006761-M2021321

Details and patient eligibility

About

To analyze the positive rate of tumor markers (TM) among health examination population in a tertiary grade A class hospital, compare the differences between different age and sex groups, and explore the possible influencing factors of TM positive.

Full description

From January 2019 to December 2019, who underwent physical examination in Peking University Third Hospital were included in the study. The expression levels of carcinoembryonic antigen (CEA),α-fetoprotein (AFP), carbohydrate antigen 19-9 (CA 19-9), carbohydrate antigen-125 (CA-125), carbohydrate antigen 72-4(CA 72-4), carbohydrate antigen 15-3 (CA 15-3), carbohydrate antigen 242(CA 242), squamous cell carcinoma antigen(SCC), CYFRA21-1, total prostate-specific antigen (TPSA ) , free prostate-specific antigen(FPSA), neuron specific enolase(NSE) were detected by Electro chemistry luminescence method. The positive rates of TM were analyzed by descriptive statistical method Explore. The differences between different age and sex groups and the influencing factors were explored by statistic by Inferential statistical method.

Enrollment

26,891 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Those who have taken a physical examination and performed at least one TM test

Exclusion criteria

  • Basic information is missing and cannot be retrieved
  • The patient was diagnosed with malignant tumor before examination
  • Those who have not done any TM tests

Trial design

26,891 participants in 1 patient group

physical examination population
Description:
From January 2019 to December 2019, who underwent physical examination in Peking University Third Hospital were included in the study.
Treatment:
Other: no intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems